Search

Your search keyword '"Anzalee Khan"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Anzalee Khan" Remove constraint Author: "Anzalee Khan" Topic schizophrenia Remove constraint Topic: schizophrenia
35 results on '"Anzalee Khan"'

Search Results

1. The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS)

2. Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS)

3. Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients

4. Assessing instrumental activities of daily living (iADL) with a game-based assessment for individuals with schizophrenia

5. Cross-cultural adaptation of the Arabic Positive and Negative Syndrome Scale in schizophrenia: Qualitative analysis of a focus group

6. Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes

7. Differential improvement of negative-symptom subfactors after cognitive remediation in low-functioning individuals with schizophrenia

8. Transcranial direct-current stimulation in ultra-treatment-resistant schizophrenia

9. Does social cognition training augment response to computer-assisted cognitive remediation for schizophrenia?

10. Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial

11. Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS)

12. The evolution of illness phases in schizophrenia: A non-parametric item response analysis of the Positive and Negative Syndrome Scale

13. T43. TRANSCRANIAL DIRECT-CURRENT STIMULATION (TDCS) IN PATIENTS WITH ULTRA-TREATMENT-REFRACTORY AUDITORY HALLUCINATIONS

14. A new Integrated Negative Symptom structure of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia using item response analysis

15. Validation of the Five-Factor Model of the Arabic Version of the Positive and Negative Syndrome Scale in Schizophrenia

16. Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia

17. The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits

18. Validity and Reliability of the Arabic Version of the Positive and Negative Syndrome Scale

19. Relationship between metabolic syndrome and cognition in patients with schizophrenia

20. Improving Social Cognition in Schizophrenia: A Pilot Intervention Combining Computerized Social Cognition Training With Cognitive Remediation

21. Ziprasidone's Effect on Metabolic Markers in Patients with Diabetes and Chronic Schizophrenia

22. A Randomized, Double-Blind, Parallel-Group, Fixed-Dose, Clinical Trial of Quetiapine at 600 Versus 1200 mg/d for Patients With Treatment-Resistant Schizophrenia or Schizoaffective Disorder

23. F63. COGNITIVE CORRELATES OF THE NEGATIVE SYMPTOMS EXPRESSIVE AND EXPERIENTIAL DEFICIT FACTORS IN PSYCHOSIS

24. A Randomized Controlled Trial of Olanzapine Versus Haloperidol in the Treatment of Primary Negative Symptoms and Neurocognitive Deficits in Schizophrenia

25. COMT genotype and response to cognitive remediation in schizophrenia

26. 43. Cognitive Functioning in First-Episode Psychosis:_x000B_ Comparison of a 2-Year Coordinated Specialty Care Program to Community Care

27. Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS)

28. Use of NON-PARAMETRIC Item Response Theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS)

29. Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia

30. Assessment of Therapy-Resistant Schizophrenia

31. Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study

32. Schizophrenia: measurements of psychopathology

33. Pharmacological treatment strategies for schizophrenia

34. EPA-0121 – How to measure social cognition in schizophrenia? a comparison of measurements

35. Reliability, validity and factorial structure of the Arabic version of the international suicide prevention trial (InterSePT) scale for suicidal thinking in schizophrenia patients in Doha, Qatar

Catalog

Books, media, physical & digital resources